Key result
HEARTS program linked to ~71% increase in hypertension control at 5 months.
Why the study?
Blood pressure trajectories and hypertension control among patients enrolled in the HEARTS program in south-west Trinidad were not previously described.
Does the HEARTS program treatment protocol improve blood pressure and hypertension control in primary care patients with elevated blood pressure?
Cohort (n=548)
Yes
Does the HEARTS program treatment protocol improve blood pressure and hypertension control in primary care patients with elevated blood pressure?
Odds Ratio: 1.71 (95% CI 1.16–2.51)
Absolute Event Rate: 70% vs 41%
p-value: p=0.006
Implementation of the WHO HEARTS program in routine primary care was associated with significant improvements in blood pressure and hypertension control over 5 months.
May support HEARTS for short-term control in primary care; leaves open causality and durability in larger randomized studies.
Objective. To describe blood pressure trajectories and hypertension control among patients enrolled in the HEARTS program in south-west Trinidad. Methods. This retrospective longitudinal cohort study used routinely collected HEARTS program data from 31 public primary health centers in the South-West Regional Health Authority, Trinidad and Tobago. Eligible patients initiated HEARTS between 1 April and 31 October 2023, with a baseline program record and at least one follow-up blood pressure measurement. Follow-up was categorized as month-1 to month-5. McNemar’s test assessed paired baseline versus month-5 control status; linear and generalized linear mixed-effects models assessed blood pressure trajectories and hypertension control. Results. The analytic cohort included 548 patients; 63.3% were female and mean age was 61.4 ± 11.0 years. At baseline, 80.7% had uncontrolled hypertension. Mean baseline systolic blood pressure was 155 ± 22 mmHg and diastolic 86 ± 14 mmHg. Among 502 patients with paired baseline and month-5 data, more patients transitioned from uncontrolled to controlled hypertension than the reverse (70 vs 41; McNemar OR 1.71, 95% CI [1.16, 2.51], p = 0.006). In mixed-effects analyses, month was associated with lower systolic blood pressure. Odds of hypertension control were higher at month-2 and month-5 relative to baseline, while higher body mass index (BMI) was associated with lower odds of control. Conclusions. Among patients with available follow-up data, the HEARTS program was associated with improved hypertension control in routine primary care, while higher BMI was associated with lower odds of control. These findings should be interpreted as observational program outcomes rather than evidence of a causal program effect.
No takes yet. Share an insight, caveat, or question.
- et al. (2026) conducted a cohort in Hypertension (n=548). HEARTS program vs. Baseline was evaluated on Hypertension control status at month-5 (transition from uncontrolled to controlled vs controlled to uncontrolled) (OR 1.71, 95% CI 1.16, 2.51, p=0.006). The HEARTS program was associated with improved hypertension control at 5 months, with more patients transitioning from uncontrolled to controlled status than the reverse (OR 1.71).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: